• Linkedin
  • Twitter
  • Pinterest
  • Vimeo
  • Skype
  • Gplus
  • Youtube
  • Rss
  • Home
  • Events
  • Careers at CAPTIS
  • Log In / Sign In ▼
    • Log In with LinkedIn
    • Register w/out LinkedIn
    • Login w/out LinkedIn
    • Reset Lost Password
  • 🔒 MEMBER AREA ▼
    • View your profile
    • Edit your profile
    • Log out
       ☎ US Offices 1 (800) 445-1839 Toll Free | Europe/Int'l +41 22 518 2100
CAPTIS Executive Search
  • Home
  • You are a Business
    • Executive Search
    • Our Commitments
    • Other Services
    • Our Locations
    • About Us
    • Key Values
  • You are a Healthcare Executive
    • Dealing with CAPTIS
    • Candidate Contact Form
    • Login with LinkedIn
    • Create an Account
    • Log in (Existing Account)
    • WW Trade Shows
      • Medical & Pharmaceutical
      • Orthopedics
      • Spine
      • Cardiovascular
      • Diagnostics
      • Wound Care
      • Plastic & Aesthetic Surgery
      • Surgery
      • Trauma
      • Pediatric Care
    • Industry News
      • News
      • Wall Street Beat
      • Business/Financial News
      • Clinical Trials
      • Musculoskeletal News Roundup
      • Cardiovascular
      • M&A Activity
      • Food & Drug Administration (FDA)
      • Wound Care
      • Practice Management
  • CAPTIS Magazine
    • Healthcare News
    • @CaptisCorp Twitter Timeline
    • Healthcare Events
    • CAPTIS LinkedIn Timeline
    • Articles ➜
      • Recruiting
      • Personal Development
      • News
  • Make an Inquiry
  • Contact Us
    • General Contact Form
    • Healthcare Executive Contact
    • Apply for a position at CAPTIS
    • Call 1 800 445 1839
      (Cell/Mobile US & Canada Toll Free, or Skype)
    • Call +41 22 518 2100
      (Cell/Mobile Swiss Landline Switchboard, or Skype)
  • Search
  • Menu

Captare. Aestimare. Eligere. Succedere.

CAPTIS – Your Global Healthcare & MedTech Executive Search Provider

You are a Business

You are an Executive

Want to work at CAPTIS

Learn about our services

 

 

Executive Search
Submit an inquiry

GET HEADHUNTED!

Create and/or update

your confidential profile

 

Healthcare Executive General Information
Create an account & Add your profile

Go to our Careers page

 

 

 

 

 

CAPTIS Careers

Recent Healthcare News:

08/20/2019/by CAPTIS

Knopp begins phase 2 trial for oral dexpramipexole in eosinophilic asthma

Recruitment in the trial is underway and the first patient has…
08/20/2019/by CAPTIS

FDA grants fast track status to Moderna’s Zika vaccine

08/20/2019/by CAPTIS

Angel-funded Siamab completes £166m exit with large commercial-stage biopharma

08/19/2019/by CAPTIS

Xynomic Research Institute successfully designs series of potent RET kinase inhibitors

08/19/2019/by CAPTIS

AbbVie receives FDA approval of RINVOQ for moderate to severe rheumatoid arthritis

08/19/2019/by CAPTIS

Celgene gets FDA approval for myelofibrosis treatment Inrebic

08/16/2019/by CAPTIS

European Medicines Agency validates marketing application for Filgotinib for the treatment of rheumatoid arthritis

08/16/2019/by CAPTIS

GeneCentric Therapeutics acquires Select ImmunoGenomics

08/15/2019/by CAPTIS

Roche gets FDA nod for Rozlytrek to treat ROS1-positive NSCLC

08/14/2019/by CAPTIS

Lynparza plus bevacizumab meets primary endpoint in PAOLA-1 trial

08/14/2019/by CAPTIS

Lilly announces superiority of Taltz versus TREMFYA in IXORA-R trial

The IXORA-R trial is the first completed head-to-head (H2H) trial…
08/14/2019/by CAPTIS

Landos Biopharma completes £49.7m series B financing

08/14/2019/by CAPTIS

Boehringer Ingelheim, MD Anderson to jointly advance new cancer therapies

08/14/2019/by CAPTIS

Janssen gets EC approval for two new indications of Imbruvica

08/13/2019/by CAPTIS

Kedrion Biopharma announces enrollment of first patient in CARES10 trial

08/13/2019/by CAPTIS

Novartis’ Sandoz to appeal US district court ruling on biosimilar Erelzi

08/13/2019/by CAPTIS

Eidos Therapeutics confirms receipt of non-binding proposal from BridgeBio Pharma to acquire shares

08/13/2019/by CAPTIS

Jazz Pharmaceuticals buys biotechnology firm Cavion for £259m

08/12/2019/by CAPTIS

Ascletis opens Clinical Development Shanghai Center

08/12/2019/by CAPTIS

Neoleukin Therapeutics, Aquinox Pharmaceuticals complete merger transaction

Go to the Healthcare News

Recent news from your industry: Finance, M&A, Products, Companies and more…

Upcoming Events:

We Suggest:

AstraZeneca’s Tagrisso meets secondary endpoint in phase III lung cancer study

0 Comments
/
08/12/2019
The company has announced positive OS results from the phase…
Read more
https://www.captis.com/wp-content/uploads/2017/02/004.jpg 450 900 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-08-12 00:31:062019-08-12 00:31:07AstraZeneca’s Tagrisso meets secondary endpoint in phase III lung cancer study

Sesen Bio reports data update from phase 3 trial for high-risk non-muscle invasive bladder cancer

0 Comments
/
08/09/2019
The updated preliminary Phase 3 clinical data will serve as the…
Read more
https://www.captis.com/wp-content/uploads/2017/02/004.jpg 450 900 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-08-09 04:01:112019-08-09 04:01:12Sesen Bio reports data update from phase 3 trial for high-risk non-muscle invasive bladder cancer

Kala Pharmaceuticals receives FDA complete response letter for KPI-121 0.25% NDA

0 Comments
/
08/09/2019
The FDA indicated that efficacy data from an additional clinical…
Read more
https://www.captis.com/wp-content/uploads/2017/02/004.jpg 450 900 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-08-09 03:31:342019-08-09 03:31:34Kala Pharmaceuticals receives FDA complete response letter for KPI-121 0.25% NDA

Bayer to buy remaining stake in BlueRock Therapeutics

0 Comments
/
08/09/2019
The deal also includes an additional payment of $360m (£296.2m)…
Read more
https://www.captis.com/wp-content/uploads/2017/02/004.jpg 450 900 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-08-09 00:31:172019-08-09 00:31:18Bayer to buy remaining stake in BlueRock Therapeutics

Vesselon acquires FDA-approved Lipid Microsphere Drug Imagent for therapeutic platform

0 Comments
/
08/08/2019
Vesselon will use Imagent to create novel therapeutic complexes…
Read more
https://www.captis.com/wp-content/uploads/2017/02/004.jpg 450 900 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-08-08 04:01:142019-08-08 04:01:14Vesselon acquires FDA-approved Lipid Microsphere Drug Imagent for therapeutic platform

Lynparza phase III PROfound trial in HRR mutation-selected metastatic castration-resistant prostate cancer met primary endpoint

0 Comments
/
08/08/2019
Results from the trial showed a statistically-significant and…
Read more
https://www.captis.com/wp-content/uploads/2017/02/004.jpg 450 900 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-08-08 04:01:132019-08-08 04:01:13Lynparza phase III PROfound trial in HRR mutation-selected metastatic castration-resistant prostate cancer met primary endpoint

Permira to buy small molecule company Cambrex for £1.97bn

0 Comments
/
08/08/2019
As per terms of the merger deal, Cambrex shareholders will secure…
Read more
https://www.captis.com/wp-content/uploads/2017/02/004.jpg 450 900 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-08-08 00:31:102019-08-08 00:31:11Permira to buy small molecule company Cambrex for £1.97bn

GSK grants license for Ebola vaccines to Sabin Vaccine Institute

0 Comments
/
08/07/2019
The agreements between GSK and Sabin in this regard are for advancing…
Read more
https://www.captis.com/wp-content/uploads/2017/02/004.jpg 450 900 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-08-07 05:01:142019-08-07 05:01:15GSK grants license for Ebola vaccines to Sabin Vaccine Institute

Stoke Therapeutics granted FDA orphan drug designation for STK-001 for Dravet Syndrome

0 Comments
/
08/07/2019
Dravet syndrome is a severe and progressive genetic epilepsy,…
Read more
https://www.captis.com/wp-content/uploads/2017/02/004.jpg 450 900 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-08-07 03:31:372019-08-07 03:31:37Stoke Therapeutics granted FDA orphan drug designation for STK-001 for Dravet Syndrome

Ontario provides access to Biktarvy for treatment of HIV

0 Comments
/
08/07/2019
“To help support the long-term health of people living…
Read more
https://www.captis.com/wp-content/uploads/2017/02/004.jpg 450 900 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-08-07 01:01:462019-08-07 01:01:47Ontario provides access to Biktarvy for treatment of HIV

Aquinox to buy biopharmaceutical firm Neoleukin Therapeutics

0 Comments
/
08/07/2019
Neoleukin is involved in the creation of next-generation immunotherapies…
Read more
https://www.captis.com/wp-content/uploads/2017/02/004.jpg 450 900 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-08-07 00:01:282019-08-07 00:01:29Aquinox to buy biopharmaceutical firm Neoleukin Therapeutics

Alnylam’s givosiran gets FDA priority review for acute hepatic porphyria

0 Comments
/
08/06/2019
Givosiran, which has been developed to be subcutaneously administered,…
Read more
https://www.captis.com/wp-content/uploads/2017/02/004.jpg 450 900 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-08-06 05:32:252019-08-06 05:32:26Alnylam’s givosiran gets FDA priority review for acute hepatic porphyria

HCL Technologies and Oracle Health Sciences collaborate to accelerate mHealth in clinical trials

0 Comments
/
08/06/2019
The collaboration includes the availability of HCL’s Faster…
Read more
https://www.captis.com/wp-content/uploads/2017/02/004.jpg 450 900 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-08-06 03:31:032019-08-06 03:31:03HCL Technologies and Oracle Health Sciences collaborate to accelerate mHealth in clinical trials

Lilly announces positive results for Emgality from CONQUER study

0 Comments
/
08/06/2019
The CONQUER study was designed and conducted based on findings…
Read more
https://www.captis.com/wp-content/uploads/2017/02/004.jpg 450 900 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-08-06 01:31:012019-08-06 01:31:02Lilly announces positive results for Emgality from CONQUER study

Roche’s Tecentriq plus platinum-based chemotherapy improves PFS in bladder cancer study

0 Comments
/
08/06/2019
The study has achieved its co-primary endpoint of investigator-assessed…
Read more
https://www.captis.com/wp-content/uploads/2017/02/004.jpg 450 900 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-08-06 00:31:002019-08-06 00:31:00Roche’s Tecentriq plus platinum-based chemotherapy improves PFS in bladder cancer study

FDA approves Daiichi Sankyo’s Turalio for rare joint tumour

0 Comments
/
08/05/2019
The approval for Turalio is for the treatment of adults with…
Read more
https://www.captis.com/wp-content/uploads/2017/02/004.jpg 450 900 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-08-05 20:01:262019-08-05 20:01:27FDA approves Daiichi Sankyo’s Turalio for rare joint tumour

Antikor Biopharma and Essex Bio-Technology forge strategic alliance in FDC for cancer treatment

0 Comments
/
08/05/2019
Mahendra Deonarain, Antikor’s CEO and visiting Reader in…
Read more
https://www.captis.com/wp-content/uploads/2017/02/004.jpg 450 900 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-08-05 03:01:232019-08-05 03:01:24Antikor Biopharma and Essex Bio-Technology forge strategic alliance in FDC for cancer treatment

Transgene provides update on PHOCUS study of Pexa-Vec in liver cancer

0 Comments
/
08/05/2019
Sillajen has informed Transgene of the IDMC’s recommendation…
Read more
https://www.captis.com/wp-content/uploads/2017/02/004.jpg 450 900 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-08-05 01:31:132019-08-05 01:31:14Transgene provides update on PHOCUS study of Pexa-Vec in liver cancer

Pfizer’s rivipansel fails to meet key endpoints in phase 3 SCD study

0 Comments
/
08/05/2019
The phase 3 rivipansel evaluating safety, efficacy and time to…
Read more
https://www.captis.com/wp-content/uploads/2017/02/004.jpg 450 900 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-08-05 00:31:112019-08-05 00:31:11Pfizer’s rivipansel fails to meet key endpoints in phase 3 SCD study

Kyowa Kirin buys back Tivozanib non-oncology rights from AVEO Oncology

0 Comments
/
08/02/2019
The agreement is an amendment to the terms of the 2006 tivozanib…
Read more
https://www.captis.com/wp-content/uploads/2017/02/004.jpg 450 900 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2019-08-02 01:31:052019-08-02 01:31:05Kyowa Kirin buys back Tivozanib non-oncology rights from AVEO Oncology
PreviousNext

  • Thorough Network

  • Deep Knowledge

  • Comprehensive Process

  • Ethical Approach

  • Confidentiality

  • Assessment Capacity

99%

Percentage of successful project completion

85%

Of placed executives remain with the client company 3 or more years

  • Share on Facebook
  • Share on Twitter
  • Share on Google+
  • Share on Pinterest
  • Share on Linkedin
  • Share on Tumblr
  • Share on Vk
  • Share on Reddit
  • Share by Mail

News from Twitter

Twitter
Olea Medical
Olea Medical
@OleaMedical

⚡Can you solve this case?⚡Patient: an 84-year-old woman woke up with left sided weakness. The last well known time was 21:00 the night before. ➡️ Question: What patient management would you adapt? #Radiology #Radiologia #stroke #MRI pic.twitter.com/aOGp…

reply retweet favorite
1:33 pm · 07/23/2019 ·
Retweeted by CAPTIS
Twitter
Spineway
Spineway
@Spineway1

Des questions sur le développement de #Spineway ? Retrouvez les dernières réponses apportées aux questions des internautes sur notre page #AskOurLeaders ! ➡ bit.ly/2LqpLd0 #spine #surgery #rachis #santé #health pic.twitter.com/ym2P…

reply retweet favorite
1:31 pm · 07/23/2019 ·
Retweeted by CAPTIS
Twitter
Spineway
Spineway
@Spineway1

🎬 Testimonial from Dr. Pablo Gato (Argentina) 🎬 Do you think the Minimal #Invasive #Surgery will trust a large majority of the #spine market in the future? #Spineway #future #surgeon ⏩ bit.ly/2JlOFXT pic.twitter.com/aw7X…

reply retweet favorite
10:30 am · 07/04/2019 ·
Retweeted by CAPTIS
Twitter
BIO International Convention
BIO International Convention
@BIOConvention

Registration in the Grand Hall zipping right along at #BIO2019 this morning! We are looking forward to a great day of Partnering, education and networking. pic.twitter.com/e6Hb…

reply retweet favorite
11:12 am · 06/04/2019 ·
Retweeted by CAPTIS
Twitter
BIO International Convention
BIO International Convention
@BIOConvention

Good morning, Philadelphia! It's officially day 1 of #BIO2019-- here are today's highlights. View the full schedule of today's events in myBIO: bit.ly/2KfZcWp pic.twitter.com/w6uv…

reply retweet favorite
11:11 am · 06/04/2019 ·
Retweeted by CAPTIS
Twitter
Centinel Spine
Centinel Spine
@CentinelSpine

Congratulations to Rory Sabbatini, prodisc® athlete-ambassador, on his 6th place finish at the @CSChallengeFW. Rory and @BrianGayPGA played the green well this weekend—while educating @PGATOUR fans on spinal surgery with prodisc. bit.ly/2W9cUSb #regainyourlife

reply retweet favorite
9:47 pm · 05/28/2019 ·
Retweeted by CAPTIS
Twitter
TranS1
TranS1
@TranS1

I am lucky to work for a company that gives a person the ability to want to make every day count. TranS1 has given me the ability to stop looking back and remember how to live a life - Get back to living! #tuesdayteammember #T14life #lovewhereyouwork #lovewhatyoudo pic.twitter.com/IiCV…

reply retweet favorite
9:47 pm · 05/28/2019 ·
Retweeted by CAPTIS
Twitter
Quantum Genomics
Quantum Genomics
@QuantumGenomics

Nous profitons de la #JournéeMondialeContreLHypertension pour vous rappeler que notre mission est de développer de nouvelles thérapies innovantes pour les besoins médicaux non satisfaits dans le domaine des maladies cardiovasculaires. #Hypertension #Firibastat #QuantumGenomics pic.twitter.com/bELl…

reply retweet favorite
12:12 pm · 05/18/2019 ·
Retweeted by CAPTIS
Twitter
CAPTIS
CAPTIS
@CaptisCorp

Let's meet at #AAOS2019 in Las Vegas. Feel free to make contact. pic.twitter.com/Cybu…

reply retweet favorite
4:11 pm · 03/14/2019
Twitter
Dr. Alfredo Figueiredo
Dr. Alfredo Figueiredo
@AlfredoFig1

#LowBackPain - a good summary by the European Spine Society @EUROSPINESoc eurospinepatientline… #Orthopaedics #SpineSurgery pic.twitter.com/yo6E…

reply retweet favorite
5:05 am · 02/21/2019 ·
Retweeted by CAPTIS
Twitter
CAPTIS
CAPTIS
@CaptisCorp

Happy President's Day from CAPTIS!

reply retweet favorite
5:06 pm · 02/18/2019
Twitter
Medtronic Spine
Medtronic Spine
@Medtronic_Spine

We are saddened to share the news of the passing of Dr. Yves Cotrel. A pioneer in modern spine surgery, Dr. Cotrel's company Sofamor, was the foundation for what would become Medtronic Spine. Dr. Cotrel's contributions will live on for years to come. Condolences to his family. pic.twitter.com/JJ1Z…

reply retweet favorite
5:27 pm · 02/01/2019 ·
Retweeted by CAPTIS
Twitter
Arab Health
Arab Health
@Arab_Health

The 44th edition of Arab Health is officially now open. #ArabHealth2019 runs until the 31st of January 2019 at the Dubai World Trade Centre and the Conrad Dubai from 10 am to 6 pm. Find out more on our website or download the Arab Health 2019 show app: bit.ly/2n3Z5Q pic.twitter.com/oasI…

reply retweet favorite
5:35 pm · 01/29/2019 ·
Retweeted by CAPTIS
Twitter
Novartis Cancer
Novartis Cancer
@NovartisCancer

Cancer is not a ‘one size fits all,’ nor is the way we treat it. We are working to better understand the different ways a cancer can mutate so we can discover new approaches to treat some of the most difficult-to-treat types of the disease. #ReimagineMedicine #ESMO18 pic.twitter.com/41QL…

reply retweet favorite
6:56 pm · 10/24/2018 ·
Retweeted by CAPTIS
Twitter
Epic CV
Epic CV
@Epic_CV

Read carefully employer's directions on how to apply. #resume #resumetips

reply retweet favorite
7:47 am · 10/16/2018 ·
Retweeted by CAPTIS
Twitter
World Spine Care
World Spine Care
@WorldSpineCare

Here are 5 Tips to Avoid Back Pain from #WorldSpineDay. #Exercise #Posture #Stress #HealthyEating #Strength pic.twitter.com/AT1D…

reply retweet favorite
7:46 am · 10/16/2018 ·
Retweeted by CAPTIS
Twitter
Neurochecklists
Neurochecklists
@neurochecklists

Large-vessel giant cell arteritis: diagnosis, monitoring and management | Rheumatology | Oxford Academic academic.oup.com/rhe…

reply retweet favorite
7:40 am · 10/16/2018 ·
Retweeted by CAPTIS
Twitter
Stryker Endoscopy
Stryker Endoscopy
@StrykerEndo

Scientists have made an unexpected discovery while investigating the triggering factors of #ColonCancer: Cell stress in combination with an altered microbiota in the colon drives tumor growth. Learn more: ow.ly/JxtK30meLTY pic.twitter.com/U51Q…

reply retweet favorite
7:39 am · 10/16/2018 ·
Retweeted by CAPTIS
Twitter
Implantech
Implantech
@Implantech

If you are in Dallas attending the AAFPRS 12th International Symposium of Facial Plastic Surgery don’t miss out on this Breakfast Symposium tomorrow morning with Dr. William Binder that is sponsored by Implantech! #implantech #superiorpatientaesthetics #implantechrewards #aafprs pic.twitter.com/HCzK…

reply retweet favorite
7:38 am · 10/16/2018 ·
Retweeted by CAPTIS
Twitter
American College of Cardiology
American College of Cardiology
@ACCinTouch

Less than one month left to submit your science for #ACC19! Abstract & case submissions are due Oct. 16. Learn more: ow.ly/4nyf30lYZxh pic.twitter.com/Mnwv…

reply retweet favorite
4:46 pm · 09/26/2018 ·
Retweeted by CAPTIS
Follow @CaptisCorp

Follow CAPTIS



CAPTIS
Followon TwitterSubscribeto RSS Feed

We Recommend

Our very best and up-to-date selection of healthcare Industries' News (Products, Markets, Companies, R&D, Technology, Opportunities, Investment & Finance...).
Read at Healthcare News

CAPTIS Newsletter

Call CAPTIS

United States Offices
1 (800) 445-1839

(United States & Canada Toll Free)

Europe & International
+41 22 518 2100

© CAPTIS - Executive Search - 2017 - copyright@captis.com
  • Linkedin
  • Twitter
  • Pinterest
  • Vimeo
  • Skype
  • Gplus
  • Youtube
  • Rss
  • Events
  • For Healthcare Executives
  • Legal & Privacy Notes, GDPR & Cookies Policy
  • Client Area
X
Thank you for visiting our new website! Help us improve, let us know your feedback (Anonymous 2 min survey)
Survey
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OK, got itCookies Policy
Scroll to top